Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

8302	Companies
115121	Keywords
55446	Articles
62530	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 09/10/2024 at 16:05, 2 months 11 days ago

Jaguar Health Appoints Industry Veteran to Lead Sales for Oncology and HIV Products

Oncology Jaguar Health Gelclair Launch HIV Products Susan Krizancic
PRESS RELEASE

published on 09/10/2024 at 16:00, 2 months 11 days ago

Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care
Jaguar Health, Inc. appoints Susan Krizancic as National Sales Director for Napo Pharmaceuticals, preparing for FDA-approved Gelclair® oral mucositis product launch in October 2024

Jaguar Health FDA-approved Gelclair Susan Krizancic National Sales Director
BRIEF

published on 09/06/2024 at 16:05, 2 months 15 days ago

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference

Pharmaceuticals Virtual Presentation Jaguar Health Lisa Conte H.C. Wainwright Conference
PRESS RELEASE

published on 09/06/2024 at 16:00, 2 months 15 days ago

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference
Jaguar Health, Inc. (NASDAQ:JAGX) founder Lisa Conte to present virtually at H.C. Wainwright Global Investment Conference. Focus on plant-derived medicines for gastrointestinal distress

Gastrointestinal Distress Jaguar Health Lisa Conte H.C. Wainwright Plant-derived Medicines
BRIEF

published on 09/05/2024 at 14:35, 2 months 16 days ago

Jaguar Health Celebrates National Service Dog Month Highlighting Its Cancer Care Drugs

Cancer Care FDA Approval Jaguar Health Canalevia-CA1 Service Dogs
PRESS RELEASE

published on 09/05/2024 at 14:30, 2 months 16 days ago

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
Jaguar Health's Canalevia-CA1 drug receives FDA conditional approval for chemotherapy-induced diarrhea treatment in dogs, making it the first approved treatment for this condition

FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea Dogs
BRIEF

published on 09/04/2024 at 16:05, 2 months 17 days ago

Jaguar Health Announces Key Commercial and Development Milestones

Crofelemer Clinical Trials Jaguar Health Rare Diseases Gelclair®
PRESS RELEASE

published on 09/04/2024 at 16:00, 2 months 17 days ago

New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Jaguar Health, Inc. announces near-term activities including Gelclair launch and crofelemer trials for rare diseases. Includes Lisa Conte interview details

Jaguar Health Inc. Rare Diseases Gelclair Launch Crofelemer Trials Lisa Conte Interview
BRIEF

published on 08/27/2024 at 16:05, 2 months 25 days ago

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

Crofelemer Short Bowel Syndrome Patent Jaguar Health Intellectual Property
PRESS RELEASE

published on 08/27/2024 at 16:00, 2 months 25 days ago

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Jaguar Health, Inc. announces issuance of new patent for crofelemer to treat rare diseases like SBS and MVID, enhancing IP protection. Independent studies supported in US, EU, and MENA regions

Crofelemer Patent Jaguar Health Rare Diseases SBS

Accesswire

Published on 11/21/2024 at 22:05, 41 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 56 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 2 hours 31 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 2 hours 36 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 2 hours 46 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 3 hours 45 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 4 hours 10 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 4 hours 48 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 4 hours 54 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 4 hours 55 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 15 hours 48 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 3 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 5 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 5 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 15 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE